Emerging evidence suggests that modulating this pathway could offer novel approaches for mitigating the cognitive impairments associated with anesthesia and surgery, highlighting the need for further investigations into the intricate roles and regulatory mechanisms of the NLRP3 inflammasome within the central nervous system to uncover new therapeutic targets for POCD. The gene discussed is NLRP3; the disease is Cognitive impairment.